SCHEMBL24607453

SCHEMBL24607453

CN(C(=O)OC(C)(C)C)C1CCN(c2cc(Cl)cc3[nH]c(=O)n(C)c23)CC1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DDR1 Q08345 4/20 0.36
▸ HSD11B1 P28845 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ SPR P35270 5/20 0.33
▸ KDM4D Q6B0I6 1/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ NPY5R Q15761 1/20 0.33
▸ AAK1 Q2M2I8 1/20 0.33
▸ PDE3B Q13370 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ P2RY12 Q9H244 1/20 0.33
▸ PLD1 Q13393 1/20 0.33
▸ USP30 Q70CQ3 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ PABPC1 P11940 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ KAT6A Q92794 1/20 0.32
▸ KAT8 Q9H7Z6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31548012 0.84 PDE10A (0.38) HSD11B1PDE10ASPRKDM4DPIK3CD
SCHEMBL25122963 0.84 PDE10A (0.38) HSD11B1PDE10ASPRKDM4DPIK3CD
SCHEMBL29751429 0.78 SPR (0.38) DDR1HSD11B1PDE10ASPRKDM4D
SCHEMBL24607801 0.78 SPR (0.38) DDR1HSD11B1PDE10ASPRKDM4D
SCHEMBL24607488 0.77 AAK1 (0.39) HSD11B1PDE10ASPRKDM4DPIK3CD
SCHEMBL29751443 0.77 AAK1 (0.39) HSD11B1PDE10ASPRKDM4DPIK3CD
SCHEMBL28504211 0.73 AKR1C3 (0.46) DDR1HSD11B1PDE10AKDM4DPIK3CD
SCHEMBL24607452 0.72 PIK3CD (0.33) DDR1PDE10ASPRKDM4DPIK3CD
SCHEMBL5536857 0.72 NPY5R (0.52) PDE10ANPY5RMEN1KMT2A
SCHEMBL29197655 0.71 MCHR1 (0.40) DDR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4271664-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-11-08 — — EP disclosed
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 — — WO disclosed
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 — — WO disclosed
Send feedback